Industry-Academic Cooperation Foundation, Yonsei University;EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION;CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
The present invention relates to a novel compound and a pharmaceutical composition comprising the same as an active ingredient. The novel compound, which is obtained by means of carrying out chemical modification in a mother structure showing excellent AMP-activated protein kinase (AMPK) activation efficacy and in silico binding capacity, enables effective prevention or treatment of degenerative neurological disorders by means of effectively inducing AMP-activated protein kinase enzyme activation.
